Medicina
Departamento
University of Rome Tor Vergata
Roma, ItaliaPublicacións en colaboración con investigadores/as de University of Rome Tor Vergata (55)
2024
-
Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
2023
-
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 15-21
-
An international comparative analysis and roadmap to sustainable biosimilar markets
Frontiers in Pharmacology, Vol. 14
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553
-
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
Multiple Sclerosis and Related Disorders, Vol. 69
-
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
International Journal of Antimicrobial Agents, Vol. 62, Núm. 4
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
eClinicalMedicine, Vol. 58
-
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
American Journal of Hematology, Vol. 98, Núm. 12, pp. 1856-1868
-
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe
Clinical Infectious Diseases, Vol. 76, Núm. 9, pp. 1628-1635
-
Trigger-Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
Journal of the American Heart Association, Vol. 12, Núm. 14, pp. e028511
2022
-
Gender Differences in Takotsubo Syndrome
Journal of the American College of Cardiology, Vol. 79, Núm. 21, pp. 2085-2093
-
Happy Heart Syndrome: Frequency, Characteristics, and Outcome of Takotsubo Syndrome Triggered by Positive Life Events
JACC: Heart Failure, Vol. 10, Núm. 7, pp. 459-466
-
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin
Respiratory Research, Vol. 23, Núm. 1
-
Impact of Left Ventricular Ejection Fraction on Procedural and Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention
American Journal of Cardiology, Vol. 172, pp. 18-25
-
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms
Journal of Personalized Medicine, Vol. 12, Núm. 6
-
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe
Transplant International, Vol. 35
-
Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations
Future Virology, Vol. 17, Núm. 2, pp. 77-86
-
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
Journal of Hematology and Oncology, Vol. 15, Núm. 1
-
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
Multiple Sclerosis Journal